Cited by 5Dermatological diseases and infestationsHelminth infection and controlVector-borne infectious diseases

Efficacy of imidacloprid + moxidectin and selamectin topical solutions against the KS1 Ctenocephalides felis flea strain infesting cats

Open access
Dryden, Michael W, Payne, Patricia A, Smith, Vicki, Hostetler, Joe·2011·Parasites & Vectors

Abstract

BACKGROUND: Two studies were conducted to evaluate and compare the efficacy of imidacloprid + moxidectin and selamectin topical solutions against the KS1 flea strain infesting cats. In both studies the treatment groups were comprised of non-treated controls, 6% w/v selamectin (Revolution®; Pfizer Animal Health) topical solution and 10% w/v imidacloprid + 1% w/v moxidectin (Advantage Multi® for Cats, Bayer Animal Health) topical solution. All cats were infested with 100 fleas on Days -2, 7, 14, 21, and 28. The difference in the studies was that in study #1 efficacy evaluations were conducted at 24 and 48 hours post-treatment or post-infestation, and in study #2 evaluations were conducted at 12 and 24 hours. RESULTS: In study #1 imidacloprid + moxidectin and the selamectin formulation provided 99.8% and 99.0% efficacy at 24 hours post-treatment. On day 28, the 24 hour efficacy of the selamectin formulation dropped to 87.1%, whereas the imidacloprid + moxidectin formulation provided 98.9% efficacy. At the 48 hour assessments following the 28 day infestations, efficacy of the imidacloprid + moxidectin and selamectin formulations was 96.8% and 98.3% respectively. In study # 2 the efficacy of the imidacloprid + moxidectin and selamectin formulations 12 hours after treatment was 100% and 69.4%, respectively. On day 28, efficacy of the imidacloprid + moxidectin and selamectin formulations 12 hours after infestation was 90.2% and 57.3%, respectively. In study #2 both formulations provided high levels of efficacy at the 24 hour post-infestation assessments, with selamectin and imidacloprid + moxidectin providing 95.3% and 97.5% efficacy, following infestations on day 28. CONCLUSIONS: At the 24 and 48 hour residual efficacy assessments, the imidacloprid + moxidectin and selamectin formulations were similarly highly efficacious. However, the imidacloprid + moxidectin formulation provided a significantly higher rate of flea kill against the KS1 flea strain infesting cats at every 12 hour post-infestation residual efficacy assessment. Both formulations should provide excellent flea control for an entire month on cats.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1756-3305-4-174

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Infestation is diagnosed only when the home is already contaminated with hundreds to thousands of flea life stages, potentially causing continuous re-infestations for the pet.

    “This results in an infestation diagnosed only when the home is already contaminated with hundreds to thousands of flea life stages, potentially causing continuous re-infestations for the pet [102,145,146].”
  • The KS1 cat flea strain has been maintained at Kansas State University, USA, since 1990 and has varying levels of resistance or reduced susceptibility to different compounds.

    “Interestingly, several studies have evaluated parasiticides against the “KS1 cat flea strain”, which has been maintained at the Kansas State University, USA, since 1990 and has varying levels of resistance or reduced susceptibility to different compounds [146].”
  • The susceptibility of the KS1 strain to different formulations at varying regimens is clear evidence of the efficacy of compounds presently marketed in controlling pulicosis for about an entire month.

    “However, the susceptibility of this strain to different formulations at varying regimens (e.g. lufenuron, spinosad, imidacloprid + moxidectin, selamectin and others out of the scope of this review) is clear evidence of the efficacy of compounds presently marketed in controlling pulicosis for about an entire month [135,146,179,180].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dryden, M. W., Payne, P. A., Smith, V., & Hostetler, J.
Affiliations
Kansas State University (US)
Corresponding author
Dryden, Michael W
Venue
Parasites & Vectors
Published
2011-09-13
Volume
4
Issue
1
Pages
174-174
ISSN
1756-3305 (ISSN-L)
OpenAlex
W2125279107
Cited by
5
References
19
Citations by year
2017: 1 · 2014: 1 · 2013: 2 · 2012: 1
FWCI
0.87
Type
journal article
Language
en
Open access
Locations
  • Parasites & Vectors (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Bayer Animal Health
Topics
  • Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
  • Health Sciences › Veterinary › Small Animals › Helminth infection and control
  • Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
Keywords
flea control, Ctenocephalides felis, imidacloprid, moxidectin, selamectin, cats, treatment efficacy, pyrethroid insecticides, acaricides, flea infestation, product comparison, skin irritation, allergic contact dermatitis
MeSH terms
Neonicotinoids, Animals, Antiparasitic Agents, Cat Diseases, Cats, Drug Evaluation, Drug Therapy, Combination, Female, Imidazoles, Insecticides, Ivermectin, Male, Nitro Compounds, Random Allocation, Treatment Outcome, Macrolides, Ctenocephalides, Flea Infestations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review